SSA
SGHT icon

Schonfeld Strategic Advisors’s Sight Sciences SGHT Stock Holding History

Schonfeld Strategic Advisors’s Portfolio SGHT Stock Details SGHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-29,500
Closed -$360K – 2595
2022
Q4 		$360K Buy
+29,500
New +$280K ﹤0.01% 1710

Other funds holding SGHT

DCP
D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return
KL
KCK Ltd Hamilton, Bermuda $15.1M AUM 30.14% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
AMH
Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return

Schonfeld Strategic Advisors's SGHT Position: Q1 2023 in Review

Schonfeld Strategic Advisors sold out of Sight Sciences (SGHT) in Q1 2023, closing a stake of 29,500 shares — an estimated $360K sold.

Schonfeld Strategic Advisors first reported a position in SGHT in Q4 2022 and held it in 1 quarter. The position peaked at $360K in Q4 2022. 75 funds tracked by Wall St. Rank hold SGHT as of Q1 2023.

  • Schonfeld Strategic Advisors reported no remaining Sight Sciences position as of Q1 2023 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 29,500 Sight Sciences shares in Q1 2023, an estimated $360K.
  • Schonfeld Strategic Advisors first reported a position in Sight Sciences in Q4 2022 and held it in 1 quarter.
  • Schonfeld Strategic Advisors's Sight Sciences position peaked at $360K in Q4 2022.
  • 75 funds tracked by Wall St. Rank held Sight Sciences as of Q1 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2023, filed 15 May 2023.